SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

6 Months Ended

Jun. 30, 2019

Revenue by payor class as a percentage of total net service revenue is as follows:



	For the Three-Month Periods Ended June 30				For the Six-Month Periods Ended June 30
	2019		2018		2019		2018
Home Health:
Medicare	44	%	50	%	45	%	51	%
Non-Medicare - Episodic-based	9	%	8	%	9	%	8	%
Non-Medicare - Non-episodic based	12	%	12	%	12	%	12	%
Hospice (1):
Medicare	30	%	24	%	29	%	23	%
Non-Medicare	1	%	1	%	1	%	1	%
Personal Care	4	%	5	%	4	%	5	%
	100	%	100	%	100	%	100	%
(1) Acquired Compassionate Care Hospice on February 1, 2019 and RoseRock Healthcare on April 1, 2019.

Schedule of Fair Value of Financial Instruments

The following details our financial instruments where the carrying value and the fair value differ (amounts in millions):



	Fair Value at Reporting Date Using
Financial Instrument	Carrying Value as of June 30, 2019		Quoted Prices in Active Markets for Identical Items (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Long-term obligations	$	274.8	$	—	$	268.5	$	—

Schedule of Weighted-Average Shares Outstanding

The following table sets forth, for the periods indicated, shares used in our computation of the weighted-average shares outstanding, which are used to calculate our basic and diluted net income attributable to Amedisys, Inc. common stockholders (amounts in thousands):



	For the Three- Month Periods Ended June 30,		For the Six- Month Periods Ended June 30,
	2019	2018	2019	2018
Weighted average number of shares outstanding - basic	32,075	33,439	32,038	33,705
Effect of dilutive securities:
Stock options	537	425	548	381
Non-vested stock and stock units	321	315	327	305
Weighted average number of shares outstanding - diluted	32,933	34,179	32,913	34,391
Anti-dilutive securities	159	57	143	88